Search by Drug Name or NDC
NDC 72611-0874-10 Regadenoson 0.08 mg/mL Details
Regadenoson 0.08 mg/mL
Regadenoson is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Almaject, Inc.. The primary component is REGADENOSON.
Product Information
| NDC | 72611-0874 |
|---|---|
| Product ID | 72611-874_974ac1a4-cb88-6339-5b65-0d50108df695 |
| Associated GPIs | |
| GCN Sequence Number | 067721 |
| GCN Sequence Number Description | regadenoson VIAL 0.4 MG/5ML INTRAVEN |
| HIC3 | A6V |
| HIC3 Description | CARDIOVASCULAR DIAGNOSTICS,NON-RADIOPAQUE AGENTS |
| GCN | 30337 |
| HICL Sequence Number | 035625 |
| HICL Sequence Number Description | REGADENOSON |
| Brand/Generic | Generic |
| Proprietary Name | Regadenoson |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Regadenoson |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.08 |
| Active Ingredient Units | mg/mL |
| Substance Name | REGADENOSON |
| Labeler Name | Almaject, Inc. |
| Pharmaceutical Class | Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207320 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72611-0874-10 (72611087410)
| NDC Package Code | 72611-874-10 |
|---|---|
| Billing NDC | 72611087410 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (72611-874-10) / 5 mL in 1 VIAL, SINGLE-DOSE (72611-874-01) |
| Marketing Start Date | 2023-07-03 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |